Israeli-American AEYE Health wins Prix Galien Award for new AI technology helping prevent blindness
Dr. Zack Dvey-Aharon, Co-founder and CEO of AEYE Health, an Israeli digital health company, invented the AEYE-DS to make sight-saving diabetic eye exams accessible at virtually any point of care.
AEYE Health, a digital health company with Israeli-American roots, has been honored with the 2026 Prix Galien USA Award for Best Digital Health Solution. The prestigious prize recognizes an AI technology that aims to prevent blindness. At the helm of this innovative company is Dr. Zack Dvey-Aharon, Co-founder and CEO.
The groundbreaking AEYE-DS technology is an autonomous AI diagnostic tool designed to detect diabetic retinopathy, a common complication of diabetes that can lead to blindness. Diabetic retinopathy occurs when blood vessels in the retina - the light-sensitive tissue at the back of the eye - are damaged. Often, there are no early symptoms, but if left untreated, it can progress to blindness.
AEYE-DS employs portable and tabletop retinal cameras to conduct diabetic eye examinations. The device uses an FDA-cleared, fully AI diagnostic program that can provide accurate results almost instantly, without the need for a physician's interpretation. This fully autonomous approach addresses the significant barriers to care that have historically hampered early detection of diabetic retinopathy.
These barriers include limited availability of specialists, long waiting times, costs, and the inconvenience of traditional screening methods.
The AEYE-DS technology has undergone rigorous validation through three prospective, controlled pivotal phase-III clinical trials. The successful outcomes of these trials have validated the effectiveness of this innovative solution, leading to its rapid expansion across the United States.
Dr. Dvey-Aharon emphasized that while winning the Prix Galien Award is an extraordinary recognition, the company's ultimate goal is to preserve the sight of patients worldwide. Looking ahead, AEYE Health is ambitiously developing the next generation of platform, AEYE-X. This advanced system is designed to perform a broader health assessment using retinal images, potentially extending the use of retinal imaging beyond traditional eye care to identify over 100 health indications.
Written by urgent.news from Jerusalem Post's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
